Ozempic (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist that works on the appetite-control centers in the brain and slows gastric emptying
Given these promising findings, yerba mate could become a natural ally in managing obesity and type 2 diabetes, earning it the "Ozempic" comparison
Administering the wrong dose could affect your treatment
With theophylline , be alert for a rapid heartbeat, restlessness, or difficulty sleeping
Research Background AHK-Cu has been investigated in preclinical dermatological research for its effects on dermal papilla cells and hair follicle cycling
Figure from van der Aart-van der Beek AB, Nat Rev Nephrol, 2020 The Study Methods This was an international, event-driven, double-blind, parallel-group, randomized, placebo-controlled trial conducted at 387 sites in 28 countries comparing semaglutide to placebo in patients with T2DM and CKD, both being treated with baseline standard of care